Edgewise Therapeutics EWTX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$12.57M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 43.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.91% to 11.69% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +735,202 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +667,890 | 6.6% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +655,306 | 0.6% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +166,751 | 0.2% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +108,252 | 2.1% |
| FMR | Mutual Fund | 2026/Q3 | +4,472,077 | 5.1% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +2,850,417 | 9.3% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +747,091 | 0.7% |
| Tyro Capital Management, LLC | Hedge Fund | 2026/Q3 | +612,965 | 0.6% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +462,000 | 0.4% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +426,597 | 1.1% |
| Integral Health Asset Management, LLC | Hedge Fund | 2026/Q3 | +400,000 | 1.8% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +396,855 | 2.0% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +384,232 | 2.0% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +297,887 | 0.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Michael Nofi | Chief Financial Officer | Derivative Exercise and Sale | -4,442 | $45.43 | 6,495 |
| 9 Nov 2026 | Michael Nofi | Chief Financial Officer | Derivative Exercise and Retained | +6,495 | – | 6,495 |
| 30 Sep 2026 | Jonathan Fox | Independent Director | Other Acquisition | +308 | – | 25,141 |
| 12 Aug 2026 | Joanne Donovan | Chief Medical Officer | Derivative Exercise and Sale | -9,441 | $44.52 | 8,625 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Derivative Exercise and Sale | -17,971 | $44.33 | 52,488 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Other Derivative Acquisition | +100,000 | – | 100,000 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Other Derivative Acquisition | +200,000 | $43.56 | 200,000 |
| 11 Aug 2026 | Kevin Koch | Chief Executive Officer | Derivative Exercise and Retained | +21,873 | – | 52,488 |
| 11 Aug 2026 | John Moore | General Counsel | Derivative Exercise and Sale | -5,016 | $44.50 | 17,697 |
| 11 Aug 2026 | John Moore | General Counsel | Other Derivative Acquisition | +32,500 | – | 32,500 |
| 11 Aug 2026 | John Moore | General Counsel | Other Derivative Acquisition | +65,000 | $43.56 | 65,000 |
| 11 Aug 2026 | John Moore | General Counsel | Derivative Exercise and Retained | +7,483 | – | 17,697 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Other Derivative Acquisition | +32,500 | – | 32,500 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Other Derivative Acquisition | +65,000 | $43.56 | 65,000 |
| 11 Aug 2026 | Joanne Donovan | Chief Medical Officer | Derivative Exercise and Retained | +3,371 | – | 8,625 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Derivative Exercise and Sale | -5,100 | $44.50 | 31,826 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Other Derivative Acquisition | +50,000 | – | 50,000 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Other Derivative Acquisition | +100,000 | $43.56 | 100,000 |
| 11 Aug 2026 | Behrad Derakhshan | Chief Operating Officer | Derivative Exercise and Retained | +8,181 | – | 31,826 |
| 11 Aug 2026 | Michael Nofi | Chief Financial Officer | Other Derivative Acquisition | +24,375 | – | 24,375 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 12,696,203 | 11.7% | 9.6 |
| 15 Oct 2026 | 11,751,785 | 10.8% | 8.5 |
| 30 Sep 2026 | 11,224,347 | 10.3% | 5.6 |
| 15 Sep 2026 | 9,543,843 | 8.8% | 8.0 |
| 31 Aug 2026 | 9,346,141 | 8.6% | 8.0 |
| 14 Aug 2026 | 9,675,389 | 8.9% | 6.4 |
No comments yet — be the first to weigh in on EWTX.
Sign in to join the discussion.